tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Balance Sheet

Compare
535 Followers

Supernus Pharmaceuticals Balance Sheet

Supernus Pharmaceuticals's total assets for Q4 2025 were $1.45T, an increase of 102216.88% from the previous quarter. SUPN total liabilities were $390.93B for the fiscal quarter, a 105533.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.45T$ 1.37B$ 1.28B$ 1.70B$ 1.69B
Total Liabilities
$ 390.93B$ 332.34M$ 356.16M$ 816.30M$ 873.30M
Total Equity Gross Minority
$ 1.06T$ 1.04B$ 921.52M$ 886.20M$ 815.85M
Other Metrics
Currency in USD

Supernus Pharmaceuticals Debt to Assets